Back to companies

Zeria Pharmaceutical Co Ltd: Overview

Select Item

Want to continue viewing company data?

Sign up for exclusive competitive intelligence.
Company Data Subscription $329 per month (billed Annually)
Signup to View Free Sample

Zeria Pharmaceutical Co Ltd (Zeria), formerly Zeria Yakusho Kenkyusho Co Ltd, manufactures and distributes pharmaceutical and consumer health care products. The company’s pharmaceutical product range includes drugs for the treatment of ulcerative colitis, Crohn’s disease, functional dyspepsia, gastritis and ulcers, and other gastrointestinal diseases. It offers combination granules, calcium channel blockers, anti-leukopenia, and iron deficiency anemia agents. Zeria also markets OTC drugs for arthralgia and lumbalgia, physical fatigue and exhaustion; and soft drinks. The company owns production facilities in Japan, Switzerland, Denmark, and Vietnam. Zeria is headquartered in Chuo-Ku, Tokyo, Japan.

Headquarters Japan
Address 10-11, Nihombashi Kobuna-Cho, Chuo-Ku, Tokyo, 103-8351
Website www.zeria.co.jp
Telephone 81 3 36632351
No of Employees 1,690
Industry Pharmaceuticals and Healthcare
Ticker Symbol & Exchange 4559 (TYO)
Revenue (2022) $530.0M
EPS XXX
Market Cap* $810.0M
Net Profit Margin (2021) XXX 16.3%
   
* As of and is in US$
View Zeria Pharmaceutical Co Ltd financials

Explore premium data & analytics

90+

Clinical Trials

Determine Zeria Pharmaceutical Co Ltd go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

20+

Pipeline Drugs

Identify which of Zeria Pharmaceutical Co Ltd’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

20+

Marketed Drugs

Understand Zeria Pharmaceutical Co Ltd’s commercialized product portfolio to stay one step ahead of the market.

9

Sales & Consensus Forecasts

Understand the current and future drug revenue for Zeria Pharmaceutical Co Ltd and assess market opportunity for new entrants with patient population 8-year forecasts.

6

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

6

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for Zeria Pharmaceutical Co Ltd’s relevant decision makers and contact details.

4

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

 Subscribe to Company Analytics & gain access to premium industry data & analytics Subscribe to Company Analytics & gain access to premium industry data & analytics Start Here

Products and Services

Products
Granules
Calcium Channel Blockers
Anti-Leukopenia
XXX
XXX
XXX
Subscribe to Company Analytics for access to more products & services data Subscribe to Company Analytics for access to more products & services data Learn More
Image for loader

Competitor Comparison

Key Parameters Zeria Pharmaceutical Co Ltd Mitsui & Co Ltd Mochida Pharmaceutical Co Ltd Taiko Pharmaceutical Co Ltd Kowa Co Ltd
Headquarters Japan Japan Japan Japan Japan
City Chuo-Ku Chiyoda-Ku Shinjuku-Ku Osaka-Shi Nagoya
State/Province Tokyo Tokyo Tokyo Osaka Aichi
No. of Employees 1,690 44,336 1,558 264 3,840
Entity Type Public Public Public Public Private
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more

Key Financial Charts

Sales Growth

Image for loader

Net Income Growth

Image for loader
Operating Margin
Operating Margin
EPS (Earnings per Share)
EPS (Earnings per Share)
Debt to Equity Ratio
Debt to Equity Ratio
Return on Assets
Return on Assets
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
Sachiaki Ibe Chief Executive Officer; Chairman Executive Board - -
Mitsuhiro Ibe Director; Chief Operating Officer; President Executive Board - -
Hirokazu Endo Director; Executive Vice President Executive Board - -
Makoto Kishimoto Managing Director Executive Board - -
Hiroki Kato Director Non Executive Board - -
Non Dignissim Eros Proin vel Convallis 2022 XX
Non Dignissim Eros Proin vel Convallis 2022 XX
Non Dignissim Eros Proin vel Convallis 2022 XX
Gain more insight into company management & employee structure with Company Analytics Gain more insight into company management & employee structure with Company Analytics Subscribe
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer